Discal Sciatica Clinical Trial
— EPI-AMELIEOfficial title:
Comparison of a Cortivazol (ALTIM®) Infiltration of Posterior Epidural Space at L3-L4 Stage Versus an Epidural Infiltration of Cortivazol (ALTIM®) on Contact With Disco Radicular Conflict in Discal Sciatica - Controlled Randomized Trial With Double Blind Evaluation
In discal sciatica, after failure of medical treatment, the investigators propose frequently a spinal infiltration of corticoids the most closer of disco-radicular conflict. Recently, some cases of paraplegia during lumbar foraminal infiltrations have induce a reduction of indications of this type of infiltration. An alternative would be to propose a lateral epidural infiltration on contact with conflict.The objective of this study is to compare, in 112 patients with a less than 6 months discal sciatica, the efficacy on pain of a non target posterior epidural space infiltration of corticoids done at L3-L4 stage on scan control versus an epidural infiltration of the same corticoid done in lateral on contact of disco radicular conflict on scan control.
Status | Recruiting |
Enrollment | 112 |
Est. completion date | March 2017 |
Est. primary completion date | March 2017 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Informed consent - Aged from 18 to 65 years - Affiliated or benefit from an insurance regimen - Patient with a sciatic answering to the definition - Discal sciatica more than 15 days and less than 6 months - Discal hernia (scan or RMI) - Negative BHCG and normal coagulation parameters Exclusion Criteria: - History of lumbar surgery - Spinal infiltration of corticoids in 30 days before inclusion - Iode allergy - Anticoagulation therapy, unbalanced type 2 diabetes, instable HTA - Motor loss < 4 (muscular testing) - Sphincter disorder (cauda equida syndrome) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
France | CHU de Montpellier - Hôpital Lapeyronie | Montpellier | |
France | CHU Carémeau | Nîmes |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Montpellier |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain evolution on analogic visual scale (EVA) ay Day 30 | at Day 30 after infiltration | No | |
Secondary | Pain evolution on analogic visual scal (EVA) at Day 7 | at day 7 after infiltration | No | |
Secondary | Pain evolution on analogic visual scal (EVA) at month 3 | at month 3 after infiltration | No | |
Secondary | Pain evolution on analogic visual scal (EVA) at month 6 | at month 6 after infiltration | No | |
Secondary | Pain evolution on analogic visual scal (EVA) at month 12 | at month 12 after infiltration | No | |
Secondary | drug consumption at day 7 | at day 7 after infiltration | No | |
Secondary | drug consumption at month 3 | at month 3 after infiltration | No | |
Secondary | drug consumption at month 6 | at month 6 after infiltration | No | |
Secondary | drug consumption at month 12 | at month 12 after infiltration | No | |
Secondary | functional handicap at Day 7 | functional handicap is assessed by auto-questionnary | at day 7 after infiltration | No |
Secondary | functional handicap at month 3 | functional handicap is assessed by auto-questionnary | at month 3 after infiltration | No |
Secondary | functional handicap at month 6 | functional handicap is assessed by auto-questionnary | at month 6 after infiltration | No |
Secondary | functional handicap at month 12 | functional handicap is assessed by auto-questionnary | at month 12 after infiltration | No |
Secondary | professional activity recovery at Day 7 | professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why? | at day 7 after infiltration | No |
Secondary | professional activity recovery at month 3 | professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why? | at month 3 after infiltration | No |
Secondary | professional activity recovery at month 6 | professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why? | at month 6 after infiltration | No |
Secondary | professional activity recovery at month 12 | professional activity recovery is assessed by patient's interrogation: if recovery, conditions of recovery, date of recovery. If not recovery, for why? | at month 12 after infiltration | No |
Secondary | new epidural infiltration or surgery of discal hernia at Day 7 | at day 7 after infiltration | No | |
Secondary | new epidural infiltration or surgery of discal hernia at month 3 | at month 3 after infiltration | No | |
Secondary | new epidural infiltration or surgery of discal hernia at month 6 | at month 6 after infiltration | No | |
Secondary | new epidural infiltration or surgery of discal hernia at month 12 | at month 12 after infiltration | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01482897 -
Efficacy of corticoïd Infiltration Via Sacro-coccygien Hiatus in Discal Sciatica
|
Phase 3 |